Literature DB >> 26226510

Irritable bowel syndrome: dietary interventions.

Alexander Charles Ford1, Per Olav Vandvik.   

Abstract

INTRODUCTION: The prevalence of irritable bowel syndrome (IBS) varies depending on the criteria used to diagnose it, but it ranges from about 5% to 20%. IBS is associated with abnormal gastrointestinal motor function and enhanced visceral perception, as well as psychosocial and genetic factors. People with IBS often have other bodily and psychiatric symptoms, and have an increased likelihood of having unnecessary surgery compared with people without IBS. METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical question: What are the effects of dietary modification (gluten-free diet, a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols [FODMAPs]) in people with irritable bowel syndrome? We searched Medline, Embase, The Cochrane Library, and other important databases up to June 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review).
RESULTS: At this update, searching of electronic databases retrieved 33 studies. After deduplication and removal of conference abstracts, 19 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 14 studies and the further review of five full publications. Of the five full articles evaluated, three RCTs were included. Based upon their own search, the contributor(s) added two additional RCTs that did not meet Clinical Evidence inclusion criteria; these have been added to the Comment section. We performed a GRADE evaluation of the quality for two PICO combinations.
CONCLUSIONS: In this systematic overview, we categorised the efficacy for two interventions based on information relating to the effectiveness and safety of dietary modification (gluten-free diet or a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols [FODMAPs]).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26226510      PMCID: PMC4520224     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  41 in total

1.  Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study.

Authors:  B Bonaz; M Baciu; E Papillon; R Bost; N Gueddah; J F Le Bas; J Fournet; C Segebarth
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

2.  Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

Authors:  John K Marshall; Marroon Thabane; Amit X Garg; William F Clark; Marina Salvadori; Stephen M Collins
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

3.  Adequate relief as an endpoint in clinical trials in irritable bowel syndrome.

Authors:  A W Mangel; B A Hahn; A T Heath; A R Northcutt; S Kong; G E Dukes; D McSorley
Journal:  J Int Med Res       Date:  1998 Mar-Apr       Impact factor: 1.671

4.  Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.

Authors:  Derrick K Ong; Shaylyn B Mitchell; Jacqueline S Barrett; Sue J Shepherd; Peter M Irving; Jessica R Biesiekierski; Stuart Smith; Peter R Gibson; Jane G Muir
Journal:  J Gastroenterol Hepatol       Date:  2010-08       Impact factor: 4.029

5.  A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

Authors:  Emma P Halmos; Victoria A Power; Susan J Shepherd; Peter R Gibson; Jane G Muir
Journal:  Gastroenterology       Date:  2013-09-25       Impact factor: 22.682

6.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

Authors:  H Mertz; V Morgan; G Tanner; D Pickens; R Price; Y Shyr; R Kessler
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

7.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

8.  Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects.

Authors:  A Prior; D G Maxton; P J Whorwell
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

9.  A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Thomas Smyrk; Joseph A Murray; Eric Marietta; Jessica O'Neill; Paula Carlson; Jesse Lamsam; Denise Janzow; Deborah Eckert; Duane Burton; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2013-01-25       Impact factor: 22.682

10.  Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.

Authors:  Alexander C Ford; David Forman; Alastair G Bailey; Anthony T R Axon; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2008-03-26       Impact factor: 10.864

View more
  1 in total

Review 1.  Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten?

Authors:  Umberto Volta; Maria Ines Pinto-Sanchez; Elisa Boschetti; Giacomo Caio; Roberto De Giorgio; Elena F Verdu
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.